BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D Jr, Gilbert MR, Celiku O, Armstrong TS. Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival. Cancers (Basel) 2021;13:2756. [PMID: 34199348 DOI: 10.3390/cancers13112756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Casili G, Lanza M, Filippone A, Caffo M, Paterniti I, Campolo M, Colarossi L, Sciacca D, Lombardo SP, Cuzzocrea S, Esposito E. Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets? JPM 2022;12:1969. [DOI: 10.3390/jpm12121969] [Reference Citation Analysis]
2 Tesileanu CMS, Vallentgoed WR, French PJ, van den Bent MJ. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review. Eur J Cancer 2022;175:214-23. [PMID: 36152406 DOI: 10.1016/j.ejca.2022.08.016] [Reference Citation Analysis]
3 Zhang Y, Hu X, Li H, Yao J, Yang P, Lan Y, Xia H. Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation. Bioengineered 2022;13:12350-64. [DOI: 10.1080/21655979.2022.2074107] [Reference Citation Analysis]